On November 20, 2022, a panel of the Inquiry Committee approved a Consent Agreement under which the Registrant agreed to undertakings involving regular monitoring for fitness to practice nursing and a limit on practice. The concerns giving rise to the complaint included the Registrant diverting medication including narcotics from the employer and falsification of records in order to conceal the diversion activities. The terms of the Consent Agreement includes but is not limited to:
The Agreement will remain in place for a minimum of three years of continuous nursing practice.
The reasons for the Inquiry Committee decision are as follows:
The name of the Registrant has been withheld in accordance with section 39.3 (4) (a) of the Health Professions Act for the purposes of not identifying the personal health information of the Registrant respecting the condition.
The Inquiry Committee is satisfied that the terms will protect the public.